Megan E. Bock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Megan E. Bock has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Charles. R. Powell
Indiana University School of Medicine Indianapolis Indiana USA
1 shared publication - Isamu Tachibana
Department of Urology, UT Southwestern Medical Center, Dallas, TX
1 shared publication - Jon K. Hathaway
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publication - Leo Song
Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publication - Mary E. Soyster
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
1 shared publication - Ramzy T Nagle
Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publication
Latest Publications
- 1 June 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (6) , 801-807
Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared with Mesh
Objective The objective is to compare robotic sacral colpopexy (RSC) utilizing autologous fascia lata to RSC with synthetic mesh in the treatment of pelvic organ prolapse. Methods We performed a prospective non-randomized case comparison trial at a single institution. We compared RSC utilizing either synthetic mesh or autologous fascia lata in women with symptomatic pelvic organ prolapse, stages II through IV. The primary outcome was anatomic prolapse recurrence determined by the Pelvic Organ Prolapse Quantification (POP-Q) exam. Secondary outcomes included patient reported outcomes such as the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). Complications were also recorded and categorized using the Clavien-Dindo system (CD). The hypothesis is that autologous fascia lata would provide equivalent anatomic and patient reported outcomes compared to mesh while eliminating mesh related complications. Results Sixty-four women underwent RSC with 19 (29.7%) receiving fascia lata graft. The overall operative time was greater in the fascia lata group with mean fascia lata harvest time of 24.8±7.4 minutes. Intragroup comparisons of the fascia and mesh groups demonstrated significant improvement in pelvic measurements as well as patient reported outcomes. Intergroup comparison demonstrated equivalent success rates at 12.1±8.7 months follow up. There was one apical failure in the fascia lata RSC group, however the difference was not statistically significant (p=0.30). Significant complications in the fascia lata harvest group included two CD-II and one CD-IIIb. In the mesh group there was one mesh erosion requiring surgical excision (CD-IIIb). Conclusion This is the first comparison between RSC with autologous fascia lata vs. mesh. Short-term anatomic outcomes were similar with autologous fascia lata use without the risk of mesh erosion. Morbidity from graft harvest site was not trivial. These results emphasize the need for a randomized controlled trial.
- 1 June 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (6) , 801-807
Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared with Mesh
Objective The objective is to compare robotic sacral colpopexy (RSC) utilizing autologous fascia lata to RSC with synthetic mesh in the treatment of pelvic organ prolapse. Methods We performed a prospective non-randomized case comparison trial at a single institution. We compared RSC utilizing either synthetic mesh or autologous fascia lata in women with symptomatic pelvic organ prolapse, stages II through IV. The primary outcome was anatomic prolapse recurrence determined by the Pelvic Organ Prolapse Quantification (POP-Q) exam. Secondary outcomes included patient reported outcomes such as the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). Complications were also recorded and categorized using the Clavien-Dindo system (CD). The hypothesis is that autologous fascia lata would provide equivalent anatomic and patient reported outcomes compared to mesh while eliminating mesh related complications. Results Sixty-four women underwent RSC with 19 (29.7%) receiving fascia lata graft. The overall operative time was greater in the fascia lata group with mean fascia lata harvest time of 24.8±7.4 minutes. Intragroup comparisons of the fascia and mesh groups demonstrated significant improvement in pelvic measurements as well as patient reported outcomes. Intergroup comparison demonstrated equivalent success rates at 12.1±8.7 months follow up. There was one apical failure in the fascia lata RSC group, however the difference was not statistically significant (p=0.30). Significant complications in the fascia lata harvest group included two CD-II and one CD-IIIb. In the mesh group there was one mesh erosion requiring surgical excision (CD-IIIb). Conclusion This is the first comparison between RSC with autologous fascia lata vs. mesh. Short-term anatomic outcomes were similar with autologous fascia lata use without the risk of mesh erosion. Morbidity from graft harvest site was not trivial. These results emphasize the need for a randomized controlled trial.